Ensol Biosciences Inc. (XKON:140610)
South Korea · Delayed Price · Currency is KRW 14,620
+230 (1.60%)
At close: Mar 12, 2026
Ensol Biosciences Market Cap
Ensol Biosciences has a market cap or net worth of 197.77 billion as of March 13, 2026. Its market cap has decreased by -42.01% in one year.
Market Cap
197.77B
Enterprise Value
n/a
Revenue
537.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
14,620.00
Market Cap Chart
Since September 10, 2018, Ensol Biosciences's market cap has increased from 106.21B to 197.77B, an increase of 86.22%. That is a compound annual growth rate of 8.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 12, 2026 | 197.77B | 12.64% |
| Dec 30, 2025 | 175.59B | -10.18% |
| Dec 30, 2024 | 195.49B | 264.72% |
| Dec 28, 2023 | 53.60B | -23.21% |
| Dec 29, 2022 | 69.80B | -47.06% |
| Dec 30, 2021 | 131.85B | 5.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 10, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bio Solution | 279.68B |
| Genome & Company | 278.10B |
| ABION | 259.04B |
| Kangstem Biotech | 239.84B |
| ISU Abxis | 204.42B |
| Prestige Biologics | 197.88B |
| TiumBio | 196.57B |
| QuadMedicine | 180.15B |